SEC Form 4 · accession 0001127602-15-031031
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melissa Lueke
Officer — Exec VP, CFO
Period of report
Nov 5, 2015
Accepted (ET)
Nov 10, 2015 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2015 | M | 15,750 | $14.007 | A | 159,898 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $14.007 | Nov 5, 2015 | M | 15,750 | D | — | Nov 10, 2015 | Common Stock | 15,750 | 0 | D |
Explanation of responses
- F1These options became fully vested in November 2009.